Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
human umbilical cord mesenchymal stem cell exosome
- Development stage
- Unknown
- Lead developer
- Hainan Affiliated Hospital of Hainan Medical University
- Modality
- Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Administration
- Inhalation
01
Overview
Human umbilical cord mesenchymal stem cell (hUC-MSC) exosomes are extracellular vesicles (EVs) harvested from the culture supernatant of mesenchymal stem cells derived from human umbilical cord tissue. These exosomes function as paracrine effectors, carrying a cargo of proteins, lipids, and microRNAs that facilitate intercellular communication and tissue repair. In pulmonary fibrosis, these exosomes are designed to be delivered via aerosol inhalation to the distal airways. Their mechanism involves the suppression of inflammatory cell infiltration and the inhibition of the TGF-beta1/Smad3 signaling pathway, which is a key driver of myofibroblast activation and extracellular matrix deposition. The First Affiliated Hospital of the Hainan Medical College is evaluating this therapy to mitigate lung scarring and improve respiratory function in patients with idiopathic pulmonary fibrosis or other fibrotic lung diseases.
- Other names
- hUC-MSC-derived exosomesumbilical cord mesenchymal stem cell-derived exosomes
02
Targets
Receptor-interacting serine/threonine-protein kinase 1 (RIPK1)/Phosphoglycerate mutase family member 5 (PGAM5) necroptosis signaling axisSMAD (SMAD family)
Beyond the preview
Go deeper on human umbilical cord mesenchymal stem cell exosome.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on human umbilical cord mesenchymal stem cell exosome.